Retrieve available abstracts of 8 articles: HTML format
Single Articles
August 2025
PYNE L, Rossignol P, Giles C, Junek M, et al Safety and efficacy of steroidal mineralocorticoid receptor antagonists in
patients with kidney failure requiring dialysis: a systematic review and
meta-analysis of randomised controlled trials.
Lancet. 2025;406:811-820. PubMedAbstract available
SOOMRO QH, Charytan DM Requiem for mineralocorticoid blockade in maintenance dialysis.
Lancet. 2025;406:780-782. PubMed
ROSSIGNOL P, Zannad F, Massy Z, Azizi M, et al Spironolactone in patients on chronic haemodialysis at high risk of adverse
cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised,
placebo-controlled trial and updated meta-analysis.
Lancet. 2025;406:705-718. PubMedAbstract available
WALSH M, Collister D, Gallagher M, Mark PB, et al Spironolactone versus placebo in patients undergoing maintenance dialysis
(ACHIEVE): an international, parallel-group, randomised controlled trial.
Lancet. 2025;406:695-704. PubMedAbstract available
May 2025
LOU-MEDA R, Perez JB Reducing the burden of chronic kidney disease in the world.
Lancet. 2025 May 9:S0140-6736(25)00548-3. doi: 10.1016/S0140-6736(25)00548. PubMed
October 2024
RANCHIN B, Shroff R Haemodiafiltration improves survival in patients receiving dialysis.
Lancet. 2024 Oct 25:S0140-6736(24)01938-X. doi: 10.1016/S0140-6736(24)01938. PubMed
August 2024
MARECEK R, Kissling S, Teso AD, Vuignier Y, et al Chronic metabolic acidosis in a patient with diabetes on maintenance
haemodialysis: mind the anion gap.
Lancet. 2024;404:570-571. PubMed
March 2024
WONG K, Pitcher D, Braddon F, Downward L, et al Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the
UK National Registry of Rare Kidney Diseases (RaDaR) cohort.
Lancet. 2024;403:1279-1289. PubMedAbstract available